NEW YORK (GenomeWeb News) - Response Genetics today said it has struck an agreement with Hitachi Chemical that will allow Hitachi to use its genetic diagnostic testing methods and services for formalin-fixed paraffin-embedded tissue samples in Southeast Asia, Australia, and New Zealand. 
 
Hitachi will also give Response Genetics access to “potential new testing services customers” in Asia for its FFPE clinical sample testing technology, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.